17 results
8-K
EX-4.3
EFTR
eFFECTOR Therapeutics Inc
26 Jan 24
Offering Priced At-The-Market Under Nasdaq Rules
4:40pm
8-K
EX-4.1
EFTR
eFFECTOR Therapeutics Inc
26 Jan 24
Offering Priced At-The-Market Under Nasdaq Rules
4:40pm
8-K
EX-4.2
EFTR
eFFECTOR Therapeutics Inc
26 Jan 24
Offering Priced At-The-Market Under Nasdaq Rules
4:40pm
8-K
EX-4.2
EFTR
eFFECTOR Therapeutics Inc
8 Jun 23
Entry into a Material Definitive Agreement
6:11am
8-K
EX-4.1
EFTR
eFFECTOR Therapeutics Inc
8 Jun 23
Entry into a Material Definitive Agreement
6:11am
8-K
EX-4.3
yu2 wp6mwa0aa3unu
8 Jun 23
Entry into a Material Definitive Agreement
6:11am
8-K
EX-4.3
r44qe3g23ht1yq u5fri
30 May 23
Entry into a Material Definitive Agreement
4:24pm
8-K
EX-4.1
0zhyu bai
30 May 23
Entry into a Material Definitive Agreement
4:24pm
8-K
EX-4.2
etpl628x8skt
30 May 23
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
eiiv4di
1 Sep 22
Shelf registration
4:02pm
10-K
EX-4.5
j1xoj1n vwesdf
29 Mar 21
Annual report
4:18pm
8-K
EX-4.1
s5x s7c74l9
13 Jan 21
Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offering
4:30pm
S-1
EX-4.1
j91m0461ebnd75wb
18 Dec 20
IPO registration
4:33pm
S-1
EX-4.2
z45q4n
18 Dec 20
IPO registration
4:33pm
S-1
EX-4.4
s1n7v i1vb0ebo4r4ce
18 Dec 20
IPO registration
4:33pm
- Prev
- 1
- Next